West Pharmaceutical Services Inc
WST· NYSE
Released Apr 23, 2026, before the open
10-Q filed Apr 23, 2026, 23 days after period end · 0000105770-26-000049
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $844.90M | $698.00M | $695.40M | $716.60M |
| Net Income | $138.80M | $89.80M | $115.30M | $140.00M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $1.92 |
| $1.23 |
| $1.55 |
| $1.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.